FPMI - FluoroPharma Medical, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development511.381720.8611,753.5
Selling General and Administrative1,691.0482,465.4783,415.34
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-2,202.429-3,186.339-5,168.84
Income from Continuing Operations
Total Other Income/Expenses Net1,414.542896.0411,142.45
Earnings Before Interest and Taxes-787.887-2,290.298-4,026.39
Interest Expense1,261.974873.359104.132
Income Before Tax-2,049.861-3,163.657-4,130.522
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-2,049.861-3,163.657-4,130.522
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-2,049.861-3,163.657-4,130.522
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-2,573.266-3,737.691-4,692.061